UK-based mid-market private equity firm CBPE Capital has revealed that it has sold Rosemont Pharmaceuticals to US-based pharmaceuticals company Perrigo for pound 180m. CBPE acquired Rosemont in August 2006 for pound 93m. The sale to ...
Tags: CBPE, Rosemont Pharmaceuticals, Perrigo